Cargando…
Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More
Immune checkpoint inhibitors (ICI) have revolutionized the treatment of cancer worldwide. Not long ago, before the introduction of ICIs, many cancers incurred a grave prognosis on patients due to the lack of effective therapies. For instance, patients with malignant melanoma survive longer and exper...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067353/ https://www.ncbi.nlm.nih.gov/pubmed/32190487 http://dx.doi.org/10.7759/cureus.6935 |